Internal Medicine, Rheumatology · Wenatchee, WA
NPI
1679699748
Since 2007
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
820 N Chelan Ave
Wenatchee, WA, 98801
Phone (509) 663-8711
Groups this clinician bills Medicare through
Medicare paid, 2024
$156K
2,919 services
Medicare patients, 2024
1,139
Average age 73
Drug cost, 2024
$6.5M
9,577 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James C Byrd was code 99214 (office e&m - established), 841 times for 462 patients. In total James C Byrd billed 2,919 services in 26 codes, and Medicare paid $156K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 841 | 462 | $67.63 | $57K |
| 99213 Office E&M - Established | Facility | 753 | 514 | $44.33 | $33K |
| 99214 Office E&M - Established | Office | 282 | 195 | $82.04 | $23K |
| 99213 Office E&M - Established | Office | 243 | 202 | $52.18 | $13K |
| 99441 Telephone Services | Office | 219 | 172 | $41.41 | $9,068 |
| 99212 Office E&M - Established | Facility | 171 | 154 | $25.11 | $4,293 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 104 | 97 | $12.64 | $1,315 |
| 99204 Office E&M - New | Facility | 90 | 90 | $90.81 | $8,172 |
| 99212 Office E&M - Established | Office | 82 | 76 | $39.47 | $3,236 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 42 | 38 | $11.36 | $477 |
| 99203 Office E&M - New | Facility | 17 | 17 | $56.10 | $954 |
| 93280 External Electrocardiographic Monitoring | Office | 17 | 17 | $26.49 | $450 |
| 36415 Venipuncture Blood Collection | Office | 14 | 11 | $8.65 | $121 |
By year: 2022 $155K for 2,830 services; 2023 $147K for 2,710 services; 2024 $156K for 2,919 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 14 | 11 | $8.65 | $121 |
Medicare prescription drug claims, 2024
In 2024, the drug James C Byrd prescribed most often to Medicare patients was Duloxetine Hcl, with 1,165 prescriptions and refills. In total James C Byrd wrote 9,577 Medicare prescriptions that cost $6.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Duloxetine Hcl Generic | 1,165 | 2,222 | 288 | $24K |
| Hydroxychloroquine Sulfate Generic | 915 | 2,239 | 244 | $53K |
| Prednisone Generic | 884 | 1,379 | 238 | $8,652 |
| Memantine Hcl Generic | 868 | 1,470 | 208 | $26K |
| Gabapentin Generic | 716 | 1,291 | 178 | $11K |
| Methotrexate Methotrexate Sodium | 587 | 1,151 | 136 | $16K |
| Pregabalin Generic | 374 | 654 | 96 | $13K |
| Leflunomide Generic | 281 | 508 | 58 | $12K |
| Savella Milnacipran Hcl | 214 | 290 | 36 | $139K |
| Allopurinol Generic | 203 | 551 | 61 | $2,508 |
| Rinvoq Upadacitinib | 186 | 201 | 22 | $1.3M |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 181 | 324 | 34 | $12K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 166 | 370 | 41 | $2,447 |
| Amitriptyline Hcl Generic | 159 | 244 | 37 | $1,875 |
| Mycophenolate Mofetil Generic | 128 | 204 | 29 | $12K |
Brand drugs: - claims; generic drugs: 8,378 claims; opioid claims: 70.
Money and other things of value reported by the companies
No payments from drug or medical device companies to James C Byrd were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.